Skip Navigation

Press Releases

Filter Press Releases

March 17, 2016

NHLBI expands blood transfusion safety study to include Zika virus

In response to growing concerns over the mosquito-borne Zika virus, the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has expanded a study in Brazil to see if Zika virus poses a threat to the blood supply. This blood safety study -- which originally focused on another emerging mosquito-borne virus, chikungunya virus -- will help determine if Zika virus can be transmitted through transfusion.

February 24, 2016

NIH, NHLBI to host COPD Town Hall Meeting to develop National Action Plan

The National Institutes of Health is partnering with other Federal agencies to host a national meeting to develop a National Action Plan for Chronic Obstructive Pulmonary Disease, or COPD. The COPD Town Hall Meeting will take place February 29 and March 1 on the NIH campus in Bethesda, Md.

January 29, 2016

NHLBI Announces the Recipients of 2016 Orloff Science Awards

The National Heart, Lung, and Blood Institute (NHLBI) is pleased to announce the 2016 Orloff Science Awards, which recognize outstanding achievements in science and the development of novel research tools in the previous year by investigators within NHLBI’s Division of Intramural Research.

January 26, 2016

Asthma prevention study suggests vitamin D supplementation in pregnant women might affect specific immune responses in offspring

WHAT: Providing extra vitamin D to women during pregnancy raised their vitamin D levels without changing recurrent wheezing rates in their offspring by age 3 years, National Institutes of Health-supported research found. However, in these children, who are at high risk for developing asthma, blood tests showed lower levels of specific antibodies related to allergy development, if their mothers took extra vitamin D, according to results appearing in the Journal of the American Medical Association.

November 17, 2015

Specific dosage of sickle cell drug increases survival rate

WHAT: An analysis by National Institutes of Health researchers has shown that people with sickle cell anemia who took the drug hydroxyurea at the recommended dose had higher survival rates than those who took less than the recommended dose. The findings appear in the journal PLOS ONE.

November 16, 2015

NIH researchers find potential target for reducing obesity-related inflammation

Scientists at the National Institutes of Health have identified a potential molecular target for reducing obesity-related inflammation. Researchers have known that overeating (that is, excess calorie consumption) by individuals with obesity often triggers inflammation, which has been linked to such diseases as asthma and Type 2 diabetes. In their study, published recently in The Journal of Clinical Investigation (Nov.

Page 5 of 63


Subscribe to NHLBI Press Releases